Filing Flows › Envoy Medical (COCH) › Q2 2026 › vs Q1 2026
Envoy Medical (COCH) Q2 2026 vs Q1 2026 (quarter over quarter)
Envoy Medical's revenue rose $12K (+31%) from $39K in Q1 2026 to $51K in Q2 2026.
Envoy Medical, Q2 2026: revenue $51K (-35% year over year), net loss $6.0M, operating cash flow −$5.5M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $51K | $39K | $12K | +31% |
| Net loss | $6.0M | $4.4M | $1.6M | +37% |
| Costs & expenses | $6.0M | $6.0M | $35K | +0.6% |
| Operating costs | $5.6M | $6.0M | −$378K | -6% |
| Interest & other, net | $413K | −$1.6M | $2.0M | — |
| Cost of revenue | $278K | $313K | −$35K | -11% |
| Research & development | $3.1M | $3.6M | −$510K | -14% |
| Sales & marketing | $181K | $164K | $17K | +10% |
| General & admin | $2.0M | $1.9M | $150K | +8% |
| Operating cash sources | $6.0M | $4.4M | $1.6M | +37% |
| Depreciation | $74K | $73K | $1K | +1% |
| Share-based compensation | $214K | $239K | −$25K | -10% |
| Working capital & other | $238K | −$2.0M | $2.3M | — |
| Cash used in operations | $5.5M | $6.1M | −$605K | -10% |
| Net loss absorbed | $6.0M | $4.4M | $1.6M | +37% |
Questions
How much did Envoy Medical's revenue grow quarter over quarter in Q2 2026?
Envoy Medical's revenue rose $12K (+31%) from $39K in Q1 2026 to $51K in Q2 2026.